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Summary
Hereditary cerebellar ataxias (CA) are neurodegenerative disorders, clinically characterized by a cerebellar syndrome, often accompanied by other neurological or non-neurological signs. All transmission modes have been described. In autosomal dominant forms (ADCA), mutations in more than 30 genes are implicated, but the molecular diagnosis remains unknown in about 40% of the cases. Implication of ion channels has long been an on-going topic in the genetics of CA, and mutations in several channel genes have been recently connected to ADCA.
In a large family with ADCA and mild pyramidal signs, we searched for the causative variant with a combined approach of linkage analysis and whole exome sequencing.
We identified a NM_018896. 4 Taken together, these data establish CACNA1G, which is highly expressed in the cerebellum, as a gene whose mutations can cause ADCA. This is consistent with the neuropathological examination showing severe Purkinje cell loss. Our study further extends our knowledge of the link between calcium channelopathies and CA.
Hereditary cerebellar ataxias are rare clinically and genetically heterogeneous neurodegenerative disorders. 1 They are characterized by a cerebellar syndrome, associated with other neurological or extra-neurological symptoms, and are inherited in all classical transmission modes. In autosomal dominant cerebellar ataxias (ADCA), the most frequent mutations are trinucleotide CAG repeat expansions, present in seven genes 2 , coding for a polyglutamine stretch in the corresponding proteins. Next mutations in frequency are noncoding nucleotide expansions and conventional mutations that have been described in more than 20 different genes. The causative variant remains unknown, however, in about 40% of individuals with ADCA. 2; 3 Over the last few years, next generation sequencing has led to the identification of an increasing number of variants in many genes implicated in this pathology. 4 Mutations in multiple genes gathered in various common pathways have highlighted their importance in the physiopathology of ADCAs, including channels.
The first channel-coding gene to be involved in ADCAs was CACNA1A (MIM clinical data are summarized in Table 1 . The age at onset varied widely, ranging from 9 to 78 years; gait instability was the major presenting symptom (9/10). Even after decades of progression, the disability and symptoms remained mild to moderate, indicating stable cerebellar involvement. Ocular signs, including saccadic pursuit, horizontal nystagmus and transient diplopia, were often noted (7/10). Interestingly, pyramidal signs, ranging from reflex pyramidal syndrome to spastic gait, were present in 5/10 individuals. Of note, depression was reported in 3/10 individuals, and cognitive impairment in 2/10. When performed (n=5), MRI revealed predominantly vermian cerebellar atrophy and a normal pons ( Figure S1 ).
Individual AAD-SAL-233-14 (III-9 in Figure 2 ) had signed an informed consent for brain donation. She died at age 83. The left hemi-brain was examined, while samples from the right hemi-brain were frozen and kept in the brain bank GIE Microscopically, the volume of the cerebellar white matter was reduced. Bergmann gliosis and empty baskets were evidences of loss of Purkinje cells, more prominent in the vermis. In the granular layer, the number of glomeruli was decreased. The cellular density was increased in the molecular layer, which appeared loosened ( Figure 1 ).
Unusually abundant polyglycosan bodies were observed in all cerebellum layers. The neuronal density in the dentate nucleus was normal as was the density of myelinated axons in the hilus. There was no neuronal loss in the pontine nuclei. The number of neurons was reduced in the inferior olive, which appeared gliotic. The substantia nigra was normal. Polyglutamine and C9orf72 (MIM *614260) expansions had previously been excluded in all three index cases using classical procedures. Linkage analysis was performed in family AAD-SAL-233 ( Figure S2 ). Six major putative loci were detected, with maximal multipoint LOD scores ranging from +1.579 to +2.279.
Whole exome sequencing was performed in individuals AAD-SAL-233-15 (III-10 in Figure 2 ) and AAD-SAL-233-25 (IV-16 in Figure 2 ), with 85 to 87% 30x-coverage, through enrichment capture using the Sure Select All Exon 50Mb kit (Agilent) followed by 2x75bp massive parallel sequencing in the Hiseq2000 sequencer (Illumina) ( (Table S3) . Results were analyzed using the abovementioned criteria. Two index cases, AAD-GRE-319-12 (II-2 in Figure 2 ), and AAD-SAL-454-10 (III-1 in Figure 2 ), harbored the same CACNA1G NM_018896.4:
c.5144G>A: p.Arg1715His variant. No recurrence of the abovementioned PDE6C variant was observed. All detected PDE6C variants, reported in Table S4 , were present in public databases.
No conventional mutations in genes previously involved in ADCA were found in AAD-GRE-319-12 (II-2 in Figure 2 ). AAD-SAL-454-10 (III-1 in Figure Other individuals harbored various CACNA1G variants (Table S5) ; however, their pathogenic effects could not be ascertained, due to the lack of affected individuals for segregation studies, genetic elements suggesting deleterious effects, or electrophysiological anomalies (Table S6 ). Analysis of flanking variants identified two homozygous variants in the CACNA1G region (chr17:g.48652875A>G and chr17:g.48655493A>G) in individual AAD-SAL-454-10 (III-1 in Figure 2 ) that were absent in AAD-SAL-233-25 (IV-16 in Figure 2 ) and heterozygous in AAD-GRE-319-12 (II-2 in Figure 2 ), excluding a common founder effect for all three families.
We hence focused on the CACNA1G variant versus the PDE6C one, because of strict co-segregation with the disease, absence in public databases, more concordant pathogenicity prediction scores, slightly higher conservation scores (Table S2 ), lower tolerance to missense variation, extremely high expression in the cerebellum, [18] [19] [20] and the previous implication of CACNA1A as well as other ion channels in cerebellar ataxias.
To study the effect of the p.Arg1715His variant on the electrophysiological characteristics of Cav3.1, the c.5144G>A mutation was introduced into the cDNA of the human Cav3.1 channel (isoform 5, Uniprot O43497-1, 21 ) by site directed mutagenesis (QuickChange Lightning Site-Directed mutagenesis, Agilent technologies). The wild-type (WT) and mutant cDNA constructs were then transfected into HEK239T cells and macroscopic currents were recorded by wholecell patch clamp techniques. Figure 3A shows typical recordings of the calcium current generated by these channels. Several differences between the WT and the Figure 3I ) and a delayed onset of burst firing, thus increasing the interval between the bursts ( Figure 3I ). These results suggest that the p.Arg1715His channel is responsible for a decrease in the neuronal excitability. T-type Cav3 calcium channels differ from HVA-VGCCs by their ability to be activated and inactivated at low voltages, near the resting membrane potential, their faster recovery from inactivation, their slower deactivation, and a characteristic window current occurring in the range of the resting membrane potential of neurons. 31; 32 In this respect, they act as pacemakers and excitability regulators, 26 allowing cells to be depolarized at needed membrane potential for other channels'
activation. This window current is also essential for the regulation of the intracellular calcium concentration. 33 In neurons, they have two essential behaviors: triggering of a burst action potential following a low threshold calcium spike 25; 32 and rebound burst firing. 26; 31; 32 Of the three Cav3 isoforms, Cav3.1 is highly expressed in cerebellar neurons, as well as thalamic relay neurons, 18; 20 where it plays a major role in the establishment of the slow (<1Hz) sleep oscillations of non-rapid eye movement sleep (REM). 31 Gain-of-function variants are thought to participate in the spike-and-wave discharges of thalamocortical neurons in absence epilepsy through enhancement of thalamic oscillatory activities. 18; 25; 34; 35 In the cerebellum, a comprehensive study of Cav3 isoforms expression in neurons revealed that their specific patterns are correlated to various electrophysiological phenotypes. 30 In situ hybridization studies described CACNA1G mRNA in both Purkinje cells (PC) and deep cerebellar nuclei neurons (DCN). 20; 36 In DCN, Cav3.1 is predominantly expressed in a subset of large neurons exhibiting a strong ability to generate rebound burst firing after hyperpolarization. 30; 37 Pharmacological evidences confirmed that these rebound bursts are mediated by Ttype calcium channels. 38 They appear to be physiologically relevant and consistent with a response to inhibitory input from PCs. 39 Their characteristics result from interplay between T-type channels and hyperpolarization-activated cyclic-nucleotide channels (HCN). 22; 39 In PC, all three subtypes of Cav3 are expressed. 30 Cav3.1 was found at the cell body as well as at the synapse between parallel fibers (PF) and PC 19 .
At this synapse, Cav3 channels interact with intermediate conductance calciumactivated potassium channels (IKCa) to suppress the temporal summation of background excitatory postsynaptic potentials from PF through an after hyperpolarization. 22; 40 This is essential to allow the detection of sensory-relevant high frequency inputs. 22; 40 Finally, PC burst firing was shown to rely on P/Q-type calcium current. In addition, T-type channels interact with large conductance calciumactivated potassium channels (BK) to determine firing rate, burst duration and interburst interval. 41 Therefore, T-type channels, Cav3 isoforms, and, more specifically, the Cav3.1 isoform, have major roles in the PF-PC-DCN signal processing. Of note, histologically, the neuronal density appeared normal in the dentate nucleus of our affected case; marked PC loss was observed.
In mice, that show 93% Cav3.1 amino-acid sequence identity with humans, no spontaneous Cacna1g mutations have been reported; however, several models have been generated. Cacna1g null mice have no overt neurological phenotype, normal growth and normal brain pathology; 42 in particular, they have no motor defects. 43 However, they present with a non-REM sleep disturbance, 44 are resistant to pharmacologically induced absence seizures, 42 show attenuated neuropathic pain, 45 and present bradycardia and slowed atrioventricular conduction. 46 The only cerebellar anomaly linked to Cacna1g inactivation was a loss of Purkinje cells in double mutant mice lacking both Cav3.1 and the alpha1 GABA-A receptor. 43 In this mouse model, motor defects, including tremor, were exacerbated compared to mice lacking only the GABA-A receptor. Conversely, transgenic mice overexpressing Cav3.1 show spontaneous spike-and-wave discharges associated with behavioral arrest. 18 In human pathology, the role of T-type VGCCs has only been partially elucidated. In particular, no monogenic disease has clearly been linked to T-type channel gene mutations until now. 25 ; 47 CACNA1H (MIM *607904)/Cav3.2 is implicated in absence epilepsy (MIM #611942), [48] [49] [50] with several mutations leading to increased activity of the channel 51 . However, in many cases, the variant rather induces susceptibility to seizures rather than has a monogenic causative effect. 25; 49 As for CACNA1G, some variants have been described in Idiopathic Generalized Epilepsy (MIM %600669); 52 many if not all of them appear to be risk factor variants and not causative mutations. CACNA1G was also associated with autism spectrum disorder (MIM %209850), but the association was too weak to fully explain the odds ratio. 53 Finally, a large study on intellectual disability identified a homozygous CACNA1G frameshift variant in three siblings with associated cataracts, but no reported cerebellar ataxia. 54 Despite its predominant expression in PC and DCN neurons, CACNA1G was never implicated by itself in cerebellar dysfunction. In three independent ADCA families, we describe the recurrent p.Arg1715His variant in Cav3.1. There are strong genetic arguments in favor of the deleteriousness of this variant: 1/ concordance of all in silico pathogenicity predictions; 2/ absence in all examined public databases (more than 60k exomes); 3/ amino acid conservation in all orthologs, paralogs, and S4 segments of all four domains of the protein; 4/ location within a putatively linked locus ( Figure S2 ); 5/ absence of pathogenic variants in all genes previously involved in ADCA; 6/ recurrence of the mutation in three pedigrees with exclusion of a common founder effect; 7/ perfect segregation in both pedigrees where it could be verified; and 8/ location within a functionally important domain of the protein, the voltage sensor S4 segment. Importantly, in vitro studies showed that the variant altered electrophysiological characteristics of the channel, with activation at more positive voltages, an increased slope factor of the steady-state inactivation curve and, consequently, a shift of the window current towards more positive potentials. Minimal alterations in T-type VGCC properties can lead to marked alterations in firing dynamics. 55 Simulation of a DCN neuron activity carrying either WT or p.Arg1715His Cav3.1 parameters also revealed a difference in burst firing, suggesting a reduced neuronal excitability caused by the aberrant channel. As activity of the cerebellar DCN and PC neurons is involved in movement behavior, 56; 57 our findings suggest that the p.Arg1715His change of Cav3.1 could affect motor control by altering DCN activity.
All together, these elements establish CACNA1G mutations as a monogenic cause of ADCA, with a recurrence of the p.Arg1715His variant and a relatively high frequency of almost 0.6%, in our cohort, after exclusion of polyglutamine expansions (~0.3% of all ADCA). The other variants detected (Table S5) In agreement with these observations, CACNA1G KO mice are resistant to induced seizures. 42 Expectedly, a positive shift in activation properties, as in our families, should be protective or have no effect.
It is of note that, in family AAD-SAL-233, individual 14 (III-9 in Figure 2) presented with both clinical signs and pathology characteristic of Alzheimer's disease (AD). Another family member presented with ataxia and Alzheimer's type dementia, but no DNA was available for sequencing and the brain was not available.
Downregulation of CACNA1G and Cav3.1 inhibition were recently correlated, in microarrays of human tissue, mice, and cellular models, with altered APP processing, and consequently, occurrence of AD. 58 We could not determine whether the p.Arg1715His change was related to AD in this case. Nevertheless, the co-occurrence of AD at age 83 is not unexpected.
It is interesting to notice that the variant we describe, p.Arg1715His, is modifying a highly conserved arginine in the S4 segment of the domain IV of the channel. All T-type channels share a common general membrane topology with four domain repeats, each including six transmembrane segments (S1 to S6). S4 segments, through their positive arginine residues, are considered the voltage sensing elements, and their alteration is expected to affect the voltage dependency of the channel. A systematic mutagenesis study in Cav3.1 showed that loss of the outermost arginine residues in the voltage sensor S4 segment of domain IV affects the steady-state inactivation curve. 59 Our results establish that Arg1715, the third outermost arginine in domain IV (R3), also plays a role in 51 (2015) 79 (2015) 37 (2000) (I) Simulation of a DCN neuron firing using the steady state activation and inactivation values obtained for the WT (black) and the p.Arg1715His (red) channels.
The DCN model used was developed by Luthman et al. 23 using the NEURON simulation environment (https://www.neuron.yale.edu/neuron/), based on the model originally implemented in GENESIS by Steuber et al. 61 The NaP, HCN and CaLVA conductances were changed to match the "Neuron 1" model described by Steuber et al. 61 In the above-mentioned equations, V walking with one stick, unlimited walking; 5: walking with two sticks; 6: unable to walk, requiring a wheelchair; 7: bedridden SARA score: Scale for the Assessment and Rating of Ataxia *Personal numbers are followed by pedigree numbers according to figure 2.
